Alembic Limited Share Price

ALEMBICLTD

INE426A01027

Real Estate Development & Operations

Market Closed - Bombay S.E. 03:32:26 21/10/2026 pm IST			5-day change	1st Jan Change
92.00 ^INR	-3.31%		-6.36%	-8.96%

21/09	Alembic Limited(BSE:506235) dropped from S&P Global BMI Index	CI
11/08	Alembic Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Alembic Limited is an India-based company engaged in the business of development, manufacturing, and marketing of pharmaceutical products. The Company's segments include the Active Pharmaceutical Ingredients Business and the Real Estate Business. The Active Pharmaceutical Ingredients Business is engaged in the manufacturing and marketing of fermentation and chemistry-based active pharmaceutical ingredients (API). The Real Estate Business is engaged in the construction of residential and commercial real estate projects and project management and marketing consultancy. The Company provides certain commercial properties on a lease basis to various tenants. The Company is also engaged in research and development activities in Vadodara. It is also engaged in power generation through co-generation.

Employees

261

Sector

Real Estate Development & Operations

More about the company

Quotes

Date	Price	Change	Volume
21/26/21	₹92.00	-3.31%	37,898
19/26/19	₹95.15	-2.26%	37,908
16/26/16	₹97.35	+1.09%	64,774
15/26/15	₹96.30	-2.18%	57,045
14/26/14	₹98.45	+0.20%	35,594

Delayed Quote Bombay S.E.

More quotes

Stock Market
Stocks
ALEMBICLTD Stock

The best tools reserved for subscribers to boost the performance of your investments!

Market Cap	2.36TCr 25Cr 22Cr 21Cr 19Cr 35Cr 36Cr 247.63Cr 97Cr 1.24TCr 94Cr 92Cr 3.96TCr	P/E 2025	8.14x	P/E 2026	5.74x
Enterprise Value	2.27TCr 24Cr 21Cr 20Cr 18Cr 34Cr 34Cr 238.47Cr 94Cr 1.2TCr 90Cr 89Cr 3.81TCr	EV / Sales 2025	11.2x	EV / Sales 2026	7.22x
Free-Float	27.23%	Yield 2025	2.44%	Yield 2026	3.38%

21/09	Alembic Limited(BSE:506235) dropped from S&P Global BMI Index	CI
11/08	Alembic Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
19/05	Alembic Limited Recommends Dividend for the Year Ended March 31, 2026	CI
19/05	Alembic Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
23/04	Alembic Pharmaceuticals Incorporates Philippines Subsidiary	MT
12/02	Alembic Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
27/11	Bajaj Healthcare Limited Appoints Shreekumar Shankarnarayan Nair as Chief Operating Officer, Effective November 27, 2025	CI
17/11	Accenture Invests in AI Marketing Intelligence Platform Alembic	MT
17/11	Alert wrongly tagged to India's Alembic withdrawn	RE
17/11	Alembic raises $145 million to accelerate enterprise adoption of causal AI	RE
17/11	Accenture invests in Alembic to reinvent marketing measurement with data and Causal AI	RE
11/11	Alembic Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
12/25/12	Alembic Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI

04/25/04	Alembic : Annual Report 2024-25	PU
27/25/27	Supreme Court Rules Against Ex-Post Facto Environment Clearance	AQ
14/24/14	Alembic Pharmaceuticals announces USFDA Dabigatran Etexilate Capsules, 110 mg	AQ
25/24/25	Alembic Pharmaceuticals announces USFDA Final Approval for Fluphenazine Hydrochloride Tablets USP, 1 mg, 2.5 mg, 5 mg, and 10 mg	AQ
07/23/07	Alembic Pharmaceuticals - Revenue up 18% to Rs. 1486 crores in Q-1 FY24	AQ

1 day	-3.31%
1 week	-6.36%
Current month	-14.24%
1 month	-10.43%
3 months	+2.02%
6 months	+1.83%
Current year	-8.96%

1 week	91.45	99.95
1 month	91.45	112.16
Current year	70.64	117.91
1 year	70.64	117.91
3 years	70.64	169
5 years	55.52	169
10 years	25	169

Alembic Limited Share Price

Stocks

ALEMBICLTD

INE426A01027

Real Estate Development & Operations

Valuation: Alembic Limited

Chart: Alembic Limited

Latest news: Alembic Limited

Press Releases: Alembic Limited

Quotes and Performance

Price Extremes

Managers and Directors: Alembic Limited

Other Real Estate Development & Operations

Financials

Company Profile

Quotes

Manager	Title	Age	Since
Udit Chirayu Amin CEO	Chief Executive Officer	46	01/10/2025
Rasesh J. Shah DFI	Director of Finance/CFO	-	13/08/2014
Kevalkumar B. Thakkar CMP	Compliance Officer	-	01/09/2023

Director	Title	Age	Since
Chirayu Ramanbhai Amin CHM	Chairman	78	20/08/1967
Malika Chirayu Amin BRD	Director/Board Member	71	02/07/1988
Udit Chirayu Amin BRD	Director/Board Member	46	24/04/2013

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ALEMBIC LIMITED	-3.31%	-6.36%	-9.30%	+8.11%	26Cr
VINGROUP	+6.99%	+0.72%	+129.45%	+931.60%	6.06TCr
SUN HUNG KAI PROPERTIES LIMITED	+1.13%	-2.10%	+13.47%	+31.78%	3.92TCr
MITSUBISHI ESTATE CO., LTD.	+2.90%	+10.52%	+13.96%	+96.27%	2.84TCr
CHINA RESOURCES LAND LIMITED	-0.46%	-0.98%	+2.02%	+2.34%	2.76TCr
EMAAR PROPERTIES	+0.35%	+1.95%	-16.82%	+80.56%	2.76TCr
MITSUI FUDOSAN CO., LTD.	+0.78%	+6.92%	-5.85%	+40.88%	2.61TCr
CK ASSET HOLDINGS LIMITED	+0.09%	-0.27%	+19.45%	+14.85%	2.01TCr
VINHOMES	+6.92%	-4.04%	+14.44%	+177.75%	1.84TCr
ALPHA DHABI HOLDING	-0.43%	-2.92%	-32.23%	-60.39%	1.91TCr
Average	+1.50%	+1.18%	+12.86%	+132.38%	2.67TCr
Weighted average by Cap.	+2.57%	+1.73%	+30.84%	+247.63%

	2025	2026
Net sales	221.89Cr 2.35Cr 2.1Cr 1.94Cr 1.76Cr 3.31Cr 3.35Cr 23Cr 9.13Cr 116.63Cr 8.82Cr 8.64Cr 371.65Cr	239.99Cr 2.54Cr 2.27Cr 2.1Cr 1.9Cr 3.58Cr 3.62Cr 25Cr 9.87Cr 126.15Cr 9.54Cr 9.34Cr 401.98Cr
Net income	310.68Cr 3.29Cr 2.93Cr 2.72Cr 2.46Cr 4.63Cr 4.69Cr 33Cr 13Cr 163.3Cr 12Cr 12Cr 520.37Cr	317.38Cr 3.36Cr 3Cr 2.77Cr 2.51Cr 4.73Cr 4.79Cr 33Cr 13Cr 166.83Cr 13Cr 12Cr 531.6Cr
Net Debt	-44Cr -46.44L -41.38L -38.31L -34.67L -65.32L -66.1L -4.59Cr -1.8Cr -23Cr -1.74Cr -1.71Cr -73Cr	-87Cr -92.62L -82.53L -76.41L -69.15L -1.3Cr -1.32Cr -9.16Cr -3.59Cr -46Cr -3.47Cr -3.4Cr -146.39Cr